featured
Long-Term Efficacy and Safety in Psoriasis With Ustekinumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Efficacy of Ustekinumab in Patients With Moderate-to-Severe Psoriasis Treated for Up to 5 Years in the PHOENIX 1 Study
J Eur Acad Dermatol Venereol 2013 Dec 01;27(12)1535-1545, AB Kimball, KA Papp, Y Wasfi, D Chan, R Bissonnette, H Sofen, N Yeilding, S Li, P Szapary, KB GordonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.